The role of estrogens in catamenial exacerbation of epilepsy
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigates the role of estrogens in the worsening of epilepsy symptoms that occurs cyclically in women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (8)
- Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women 2021
- Diagnosis and management of catamenial seizures: a review 2012
- Catamenial epilepsy: hormonal aspects 2010
- The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy 2009
- Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy 2008
- Influence of steroid hormones in women with mild catamenial epilepsy. 2007
- Perimenstrual Catamenial Epilepsy 2007
- How Common Is Catamenial Epilepsy? 1993
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK